IL148185A0 - Method for the therapeutic management of extrauterine proliferation of endometrial tissue, chronic pelvic pain and fallopian tube obstruction - Google Patents

Method for the therapeutic management of extrauterine proliferation of endometrial tissue, chronic pelvic pain and fallopian tube obstruction

Info

Publication number
IL148185A0
IL148185A0 IL14818500A IL14818500A IL148185A0 IL 148185 A0 IL148185 A0 IL 148185A0 IL 14818500 A IL14818500 A IL 14818500A IL 14818500 A IL14818500 A IL 14818500A IL 148185 A0 IL148185 A0 IL 148185A0
Authority
IL
Israel
Prior art keywords
fallopian tube
pelvic pain
chronic pelvic
endometrial tissue
therapeutic management
Prior art date
Application number
IL14818500A
Other languages
English (en)
Original Assignee
Zentaris Ag
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Zentaris Ag filed Critical Zentaris Ag
Publication of IL148185A0 publication Critical patent/IL148185A0/xx

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/04—Peptides having up to 20 amino acids in a fully defined sequence; Derivatives thereof
    • A61K38/08—Peptides having 5 to 11 amino acids
    • A61K38/09—Luteinising hormone-releasing hormone [LHRH], i.e. Gonadotropin-releasing hormone [GnRH]; Related peptides
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P15/00—Drugs for genital or sexual disorders; Contraceptives
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P15/00—Drugs for genital or sexual disorders; Contraceptives
    • A61P15/06—Antiabortive agents; Labour repressants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P15/00—Drugs for genital or sexual disorders; Contraceptives
    • A61P15/08—Drugs for genital or sexual disorders; Contraceptives for gonadal disorders or for enhancing fertility, e.g. inducers of ovulation or of spermatogenesis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P5/00—Drugs for disorders of the endocrine system
    • A61P5/02—Drugs for disorders of the endocrine system of the hypothalamic hormones, e.g. TRH, GnRH, CRH, GRH, somatostatin
    • A61P5/04—Drugs for disorders of the endocrine system of the hypothalamic hormones, e.g. TRH, GnRH, CRH, GRH, somatostatin for decreasing, blocking or antagonising the activity of the hypothalamic hormones
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P5/00—Drugs for disorders of the endocrine system
    • A61P5/06—Drugs for disorders of the endocrine system of the anterior pituitary hormones, e.g. TSH, ACTH, FSH, LH, PRL, GH
    • A61P5/08—Drugs for disorders of the endocrine system of the anterior pituitary hormones, e.g. TSH, ACTH, FSH, LH, PRL, GH for decreasing, blocking or antagonising the activity of the anterior pituitary hormones
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P5/00—Drugs for disorders of the endocrine system
    • A61P5/24—Drugs for disorders of the endocrine system of the sex hormones
    • A61P5/26—Androgens

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Veterinary Medicine (AREA)
  • Endocrinology (AREA)
  • Chemical & Material Sciences (AREA)
  • Public Health (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Reproductive Health (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Diabetes (AREA)
  • Pregnancy & Childbirth (AREA)
  • Gynecology & Obstetrics (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Immunology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Epidemiology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
IL14818500A 1999-09-23 2000-09-20 Method for the therapeutic management of extrauterine proliferation of endometrial tissue, chronic pelvic pain and fallopian tube obstruction IL148185A0 (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US15547899P 1999-09-23 1999-09-23
PCT/EP2000/009212 WO2001021194A2 (en) 1999-09-23 2000-09-20 Method for the therapeutic management of endometriosis and fallopian tube obstruction

Publications (1)

Publication Number Publication Date
IL148185A0 true IL148185A0 (en) 2002-09-12

Family

ID=22555601

Family Applications (1)

Application Number Title Priority Date Filing Date
IL14818500A IL148185A0 (en) 1999-09-23 2000-09-20 Method for the therapeutic management of extrauterine proliferation of endometrial tissue, chronic pelvic pain and fallopian tube obstruction

Country Status (22)

Country Link
EP (1) EP1214086A2 (xx)
JP (2) JP2003509467A (xx)
KR (1) KR100772852B1 (xx)
CN (2) CN101045155A (xx)
AU (1) AU769482B2 (xx)
BG (1) BG66128B1 (xx)
BR (1) BR0014198A (xx)
CA (1) CA2383510A1 (xx)
HK (1) HK1049117A1 (xx)
HU (1) HUP0202741A3 (xx)
IL (1) IL148185A0 (xx)
MX (1) MXPA02002436A (xx)
NO (1) NO331198B1 (xx)
NZ (1) NZ534836A (xx)
PL (1) PL201898B1 (xx)
RU (1) RU2255759C2 (xx)
SK (1) SK3752002A3 (xx)
TR (1) TR200200738T2 (xx)
TW (1) TWI267373B (xx)
UA (1) UA73956C2 (xx)
WO (1) WO2001021194A2 (xx)
ZA (1) ZA200201374B (xx)

Families Citing this family (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE10157628A1 (de) * 2001-11-26 2003-06-12 Zentaris Ag Injektionslösung eines LHRH-Antagonisten
US7214662B2 (en) 2001-11-27 2007-05-08 Zentaris Gmbh Injectable solution of an LHRH antagonist
CN102089320B (zh) 2008-01-24 2015-11-25 埃斯佩兰斯医药公司 溶解结构域融合构建体及其制备和使用方法
US20120053122A1 (en) * 2009-01-22 2012-03-01 Maatschap Interne Geneeskunde Rijnstate Method for the prophylaxis or treatment of flushing
KR20210090298A (ko) 2012-10-30 2021-07-19 에스퍼란스 파마슈티컬스, 인코포레이티드 항체/약물 컨쥬게이트 및 이의 사용 방법
EP3384930A1 (en) 2013-03-15 2018-10-10 AbbVie Inc. Compositions for use in treating heavy menstrual bleeding
JP2021531236A (ja) 2018-04-19 2021-11-18 アッヴィ・インコーポレイテッド 重度の月経出血を治療する方法
EP3560555A1 (en) * 2018-04-26 2019-10-30 LifeArc A composition for treating one or more estrogen related diseases

Family Cites Families (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5064939A (en) * 1990-02-06 1991-11-12 The Salk Institute For Biological Studies Cyclic gnrh antagonists
SE9301606D0 (sv) * 1993-05-07 1993-05-07 Per-Christer Oden Composition for the treatment of impaired hair growth
DE69515666T2 (de) * 1994-07-22 2000-07-06 Hampton Roads Medical College VERWENDUNG VON GnRH-ANTAGONISTEN ZUR HERSTELLUNG EINES MEDIKAMENTS ZUR BEHANDLUNG GONADEN-STEROID ABHÄNGIGER ERKRANKUNGEN
US5658884A (en) * 1994-07-22 1997-08-19 The Medical College Of Hampton Roads Establishment of tonic ovarian estrogen secretion for extended therapeutic regimens
DE19513662A1 (de) * 1995-04-08 1996-10-10 Schering Ag Pharmazeutisches Kombinationspräparat zur hormonalen Kontrazeption
DE19604231A1 (de) * 1996-01-29 1997-07-31 Schering Ag Pharmazeutisches Kombinationspräparat und seine Verwendung zur Behandlung von gynäkologischen Störungen
WO1998009645A1 (fr) * 1996-09-04 1998-03-12 Dott Research Laboratory Compositions medicamenteuses contenant des peptides, destinees a l'administration orale
WO1998055470A1 (en) * 1997-06-05 1998-12-10 Merck & Co., Inc. Antagonists of gonadotropin releasing hormone
DE19911771B4 (de) * 1999-03-17 2006-03-30 Zentaris Gmbh LHRH-Antagonist, Verfahren zu seiner Herstellung und seiner Verwendung

Also Published As

Publication number Publication date
SK3752002A3 (en) 2003-06-03
KR20020035879A (ko) 2002-05-15
BR0014198A (pt) 2002-05-21
HUP0202741A2 (hu) 2003-01-28
NZ534836A (en) 2007-07-27
JP2003509467A (ja) 2003-03-11
CN101045155A (zh) 2007-10-03
TWI267373B (en) 2006-12-01
MXPA02002436A (es) 2003-02-12
CA2383510A1 (en) 2001-03-29
ZA200201374B (en) 2002-10-30
WO2001021194A2 (en) 2001-03-29
TR200200738T2 (tr) 2002-08-21
UA73956C2 (en) 2005-10-17
PL201898B1 (pl) 2009-05-29
CN1376070A (zh) 2002-10-23
AU769482B2 (en) 2004-01-29
HUP0202741A3 (en) 2003-12-29
NO20021430D0 (no) 2002-03-21
JP2012051920A (ja) 2012-03-15
NO331198B1 (no) 2011-10-31
BG66128B1 (bg) 2011-06-30
BG106584A (bg) 2003-02-28
AU7779200A (en) 2001-04-24
KR100772852B1 (ko) 2007-11-02
WO2001021194A3 (en) 2002-03-14
PL353244A1 (en) 2003-11-03
NO20021430L (no) 2002-05-07
HK1049117A1 (zh) 2003-05-02
RU2255759C2 (ru) 2005-07-10
EP1214086A2 (en) 2002-06-19

Similar Documents

Publication Publication Date Title
AU3734300A (en) Method and apparatus for establishing and maintaining therapeutic hypothermia
IL132760A0 (en) Vibrator for treatment of constipation
AU3968401A (en) System for warming lower extremities of supine persons
EP1404343A4 (en) THERAPEUTIC COMBINATIONS FOR THE TREATMENT OF HORMONE DEFICIENCIES
AU1227302A (en) System and method for optimizing drug therapy for the treatment of diseases
IL148185A0 (en) Method for the therapeutic management of extrauterine proliferation of endometrial tissue, chronic pelvic pain and fallopian tube obstruction
IL151891A0 (en) Quinolinyl-piperidin 4-ylidene-methyl-benzamide derivatives for the treatment of pain
IL151765A0 (en) Hydroxyphenyl-piperazinyl-methyl-benzamide derivatives for the treatment of pain
HUP0204448A3 (en) Trnasdermal therapeutic system for the delivery of lerisetron
IL130171A0 (en) Therapeutic use of melatonin
IL148166A0 (en) Drug for treating fractures
GB0228823D0 (en) Apparatus for the diagnosis and therapy of neuro-muscular and other tissue disorders
EP1171579A4 (en) TR9 HUMAN RECEPTOR OF TUMOR NECROSIS FACTORS
EP1210370A4 (en) TUMOR NECROSIS FACTOR TR16 HUMAN RECEPTOR
HUP0402664A3 (en) 2-indanylamino derivatives for the therapy of chronic pain
GB9911238D0 (en) Therapeutic use
NZ514013A (en) Treatment of hiatial hernia
GB9921953D0 (en) Therapeutic use
GB9912184D0 (en) Therapeutic use
GB9924980D0 (en) Therapeutic treatment
GB9901505D0 (en) Therapeutic treatment
GB9923551D0 (en) Treatment of neuropsychiatric disorders
GB9927198D0 (en) Ultrasound therapy
EP1165060A4 (en) PROCESSING OF BILARIAL CALCULATIONS
TW367841U (en) Improvement for massaging chair

Legal Events

Date Code Title Description
FF Patent granted
MM9K Patent not in force due to non-payment of renewal fees